# Clinical Pharmacology Study of AZD7295 in Healthy Subjects

> **NCT00906256** · PHASE1 · COMPLETED · sponsor: **Arrow Therapeutics** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD7295
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00906256
- **Lead sponsor:** Arrow Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2010-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906256, "Clinical Pharmacology Study of AZD7295 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00906256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*